Markets:

Overview

News

Currencies

International

Treasuries

Opiant Pharmaceuticals, Inc. - Common Stock (NQ:OPNT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 1, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Opiant Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio ↗

March 03, 2023

Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transaction strengthens Indivior's addiction treatment and science portfolio by...

Via Benzinga

Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

February 07, 2023

From Opiant Pharmaceuticals, Inc.

Via GlobeNewswire

Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

February 06, 2023

From Opiant Pharmaceuticals, Inc.

Via GlobeNewswire

Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose

January 19, 2023

From Opiant Pharmaceuticals, Inc.

Via GlobeNewswire

OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT

January 06, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Analyzing Opiant Pharma's Short Interest ↗

January 03, 2023

Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 148.0% since its last report. The company recently reported that it has 30 thousand shares sold short, which is 0.62% of all regular...

Via Benzinga

How Is The Market Feeling About Opiant Pharma? ↗

December 08, 2022

Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 13.79% since its last report. The company recently reported that it has 16 thousand shares sold short, which is 0.33% of all regular...

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)

December 05, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Tesla, Amazon, Opiant, Nu, Paramount: Lawsuit, Earnings, Warren Buffett's Increased Stake Draw Investor Attention ↗

November 14, 2022

Major Wall Street indices closed in the red on Monday, in a reversal of last week’s rally driven by softer inflation data.

Via Benzinga

November 14, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Looking Into Opiant Pharma's Recent Short Interest ↗

November 14, 2022

Opiant Pharma's (NASDAQ:OPNT) short percent of float has fallen 27.5% since its last report. The company recently reported that it has 14 thousand shares sold short, which is 0.29% of all regular...

Via Benzinga

Dow Surges 150 Points; Crude Oil Falls Sharply ↗

November 14, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 14, 2022

Gainers

Via Benzinga

Opiant Pharmaceuticals (NASDAQ: OPNT) Enters Into Definitive Agreement to be Acquired by Indivior for $145 Million

November 14, 2022

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) is engaged as a specialty pharmaceutical company, which is focused on developing treatments for drug

Via Spotlight Growth

Stocks Cool Off From Last Week's Rally ↗

November 14, 2022

Stocks are starting the week off lower, unable to build off of last week's impressive rally.

Via Talk Markets

Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings ↗

November 14, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday.

Via Benzinga

Party City Layoffs 2022: What to Know About the PRTY Job Cuts ↗

November 14, 2022

Party City (PRTY) is the latest company to announce layoffs as it prepares to cut 19% of its workforce due to rising inflation.

Via InvestorPlace

Why Is Opiant Pharma (OPNT) Stock Up 116% Today? ↗

November 14, 2022

Opiant Pharmaceuticals (OPNT) stock is rocketing higher on Monday following news that Indivior is acquiring the Narcan maker!

Via InvestorPlace

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points ↗

November 14, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

Via Benzinga

OPNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Opiant Pharmaceuticals, Inc. Is Fair to Shareholders

November 14, 2022

From Halper Sadeh LLC

Via Business Wire

Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14 ↗

November 14, 2022

Reuters

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 14, 2022

Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...

Via Benzinga

Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals ↗

November 14, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 14, 2022

Welcome back and get ready for the week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!

Via InvestorPlace

Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket ↗

November 14, 2022

Via Benzinga

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket ↗

September 27, 2022

Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...

Via Benzinga

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes ↗

August 12, 2022

MindMed (NASDAQ: MNMD), which recently received a letter on behalf of one of its shareholders calling for a new business strategy and offer

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.